Skip to main content

Salvinorin A Facts

Hallucinogen; Salvinorin; Kappa-opioid receptor agonist

Description

Salvinorin A (divinorin A) is a dissociative of the neoclerodane diterpene class. It activates kappa-opioid receptors in the brain — not serotonin receptors — producing a profound and unusual dissociative state.[1]

Subjective effects include intense dissociation, loss of body ownership, vivid internal imagery, ego dissolution, and amnesia.[2] The experience is defined by an abrupt, involuntary departure from ordinary reality — more commonly described as bewildering and dysphoric than expansive, setting it sharply apart from serotonergic psychedelics.[2]

Salvinorin A produces no physical dependence — its aversive character and suppression of reward-circuit dopamine make compulsive use self-limiting.[3] The primary risks are psychological: onset is near-instantaneous, and high doses produce complete incapacitation with acute danger from falls and burns.[4]

Dose and durationby route · individual sensitivity varies

Sublingual

No dose recorded for this route. The timings are not a dose guide.

Starts in 10 – 20 minLasts 30 – 90 minAfter-effects 30 – 120 min

Body and dependence

Acute toxicity
Low
Chronic toxicity
Low
Physical dependence
None
Psychological dependence
Negligible
Withdrawal
None recorded
Compulsive redosing
Negligible

Tolerance

Builds
Rapid
Fully resets after
Not recorded
Carries over to
dynorphin; U50488; pentazocine

Effectslikely at a common dose

Perception
Depth perception distortion; Holotropic state; Perspective distortion; Proprioceptive distortion; Sensory deprivation; Spatial disorientation; +14 possible, including Vestibular distortion, Visual haze / noise
Body
Body schema distortion; Dizziness; Motor control impairment; +17 possible, including Nausea, Heart rate perception changes, Trembling
Thinking
Cognitive impairment; Confusion; Decision impairment; Focus suppression; Immersion enhancement; Information processing suppression; Language suppression; Memory suppression; Thought disorganization; +13 possible, including Analysis suppression, Cognitive dysphoria, Thought loops
Feeling
none likely · 6 possible, including Anxiety, Dysphoria, Paranoia
Self
Communication suppression; Depersonalization; Derealization; +4 possible, including Social disconnection
Time
Temporal disorientation; Time alteration; +1 possible

Who shouldn't take it

Absolute
Psychotic disorders (schizophrenia, schizoaffective disorder); Unsupervised use or hazardous environments; Vehicle operation
Relative
Bipolar disorder; Concurrent opioid agonist use

Combinations60 recorded

Dangerous (35)
Ketamine, DXM, PCP; Opioids; 5-HTP, Tryptophan; Alpha-2 adrenergic receptor antagonist; Amphetamines; Anticholinergics; Antipsychotics; Atypical antipsychotics; Buspirone; Cannabis; Cannabis, THC; CBD; Dopamine agonists; DXM; Ephedrine, Pseudoephedrine; GHB, Baclofen; GHB, GBL; Lithium; Local anesthetics; MAOIs; MDMA, Amphetamines; MDMA, MDA; NDRIs (Wellbutrin); NRIs; and 11 more, see full page
Caution (18)
See full page: psychedex.org/substances/salvinorin-a
Not graded (7)
Not listed never means safe.

Seek help immediately if

No emergency profile is recorded for this substance. Not recorded never means no risk.

988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE

Version r1.a1 · Not medical advice

References

  1. [1]
    ^Roth BL, Baner K, Westkaemper R, Siebert D, Rice KC, Steinberg S, Ernsberger P, Rothman RB (2002) Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. — Proceedings of the National Academy of Sciences of the United States of America PMID:12192085
  2. [2]
    ^abMaqueda AE, Valle M, Addy PH, Antonijoan RM, Puntes M, Coimbra J, Ballester MR, Garrido M, González M, Claramunt J, Barker S, Johnson MW, Griffiths RR, Riba J (2015) Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans. — The international journal of neuropsychopharmacology doi:10.1093/ijnp/pyv065
  3. [3]
    ^Ganado M, Rubio C, Pérez-Villavicencio J, Serrano N, Romo-Parra H, Lee Á, Rubio-Osornio M (2026) Opioid Receptors in Psychedelia: Indirect Serotonergic Modulation of Direct KOR Activation by Salvinorin A. — Biomedicines doi:10.3390/biomedicines14020476
  4. [4]
    ^El-Khoury J, Sahakian N (2015) The Association of Salvia divinorum and Psychotic Disorders: A Review of the Literature and Case Series. — Journal of psychoactive drugs doi:10.1080/02791072.2015.1073815
Print version
Report an issue